chr1-63323344-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The NM_012183.3(FOXD3):c.286G>T(p.Val96Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0168 in 1,344,330 control chromosomes in the GnomAD database, including 863 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.027 ( 133 hom., cov: 33)
Exomes 𝑓: 0.016 ( 730 hom. )
Consequence
FOXD3
NM_012183.3 missense
NM_012183.3 missense
Scores
1
17
Clinical Significance
Conservation
PhyloP100: 0.549
Genes affected
FOXD3 (HGNC:3804): (forkhead box D3) This gene belongs to the forkhead family of transcription factors which is characterized by a distinct forkhead domain. Mutations in this gene cause autoimmune susceptibility 1. [provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.001522392).
BP6
Variant 1-63323344-G-T is Benign according to our data. Variant chr1-63323344-G-T is described in ClinVar as [Benign]. Clinvar id is 3037447.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.13 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FOXD3 | NM_012183.3 | c.286G>T | p.Val96Leu | missense_variant | 1/1 | ENST00000371116.4 | |
FOXD3-AS1 | NR_121637.1 | n.87+1011C>A | intron_variant, non_coding_transcript_variant | ||||
FOXD3-AS1 | NR_121636.1 | n.185+147C>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FOXD3 | ENST00000371116.4 | c.286G>T | p.Val96Leu | missense_variant | 1/1 | NM_012183.3 | P1 | ||
FOXD3-AS1 | ENST00000427268.1 | n.87+1011C>A | intron_variant, non_coding_transcript_variant | 1 | |||||
FOXD3-AS1 | ENST00000431294.7 | n.286+147C>A | intron_variant, non_coding_transcript_variant | 1 | |||||
FOXD3-AS1 | ENST00000697579.1 | n.203+129C>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0271 AC: 4117AN: 151872Hom.: 133 Cov.: 33
GnomAD3 genomes
AF:
AC:
4117
AN:
151872
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00815 AC: 108AN: 13248Hom.: 3 AF XY: 0.0109 AC XY: 73AN XY: 6694
GnomAD3 exomes
AF:
AC:
108
AN:
13248
Hom.:
AF XY:
AC XY:
73
AN XY:
6694
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0155 AC: 18486AN: 1192350Hom.: 730 Cov.: 33 AF XY: 0.0176 AC XY: 10133AN XY: 576102
GnomAD4 exome
AF:
AC:
18486
AN:
1192350
Hom.:
Cov.:
33
AF XY:
AC XY:
10133
AN XY:
576102
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0271 AC: 4118AN: 151980Hom.: 133 Cov.: 33 AF XY: 0.0287 AC XY: 2132AN XY: 74314
GnomAD4 genome
AF:
AC:
4118
AN:
151980
Hom.:
Cov.:
33
AF XY:
AC XY:
2132
AN XY:
74314
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
46
ESP6500EA
AF:
AC:
15
ExAC
AF:
AC:
310
Asia WGS
AF:
AC:
450
AN:
3460
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
FOXD3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 05, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Loss of catalytic residue at G97 (P = 0.3108);
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at